Well, while it is always going to be a little disconcerting with the lack of transparency with Cannaglobal the 5 year supply agreement (part of the sale deal) is delivering the goods - $500k and $700k sales of materials so far in the first year of the agreement. Also remember that it is not accurate to put any value on the Derma divison as it existed - it was loss making in the vicinity of 1.5-2mil per year. MXC could have just shut it down with no residual benefit which would have been a much worse scenario.
Ann: Additional Information on Ground-breaking Research, page-77
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.00M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3300 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 313 | 1 |
View Market Depth
| Last trade - 16.16pm 12/07/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable